Skip to main content
Erschienen in: World Journal of Surgery 5/2021

27.01.2021 | Original Scientific Report

Patient Outcomes Following Emergency Bowel Resection for Inflammatory Bowel Disease and the Impact of Surgical Subspecialisation in the North of England: A Retrospective Cohort Study

verfasst von: H. MacFarlane, T. E. Baldock, R. C. McLean, L. R. Brown

Erschienen in: World Journal of Surgery | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Management of inflammatory bowel disease (IBD) has changed considerably over recent years, which has coincided with increased subspecialisation amongst general surgeons. This study evaluated the demographics and outcomes of patients with IBD undergoing bowel resection and assessed for the potential impact of surgical subspecialisation.

Methods

Patient demographic, operative and outcome data were collected for patients undergoing a bowel resection secondary to IBD, admitted acutely to NHS trusts in the North of England between 2002 and 2016. The primary outcome of interest was 30-day post-operative mortality, with secondary outcomes: length of stay, stoma and anastomosis rates.

Results

A total of 913 patients were included in the study cohort. A reduction in the number of resections was noted over time (2002–2006: 361 vs. 2012–2016: 262). No change was observed for 30-day mortality over the study period (3.9%, p = 0.233). Length of stay was also unchanged (p = 0.949). Laparoscopic surgery was increasingly utilised (0.6% vs. 17.2%, p < 0.001) in recent years, and by colorectal subspecialists (p = 0.003). More patients were managed by a colorectal consultant latterly (2002–2006: 45.4% vs. 2012–2016: 63.7%, p < 0.001). There was no difference between colorectal and other subspecialists in mortality (p = 0.156), length of stay (p = 0.201), stoma (p = 0.629) or anastomosis (p = 0.659) rates, including following multivariable adjustment.

Conclusion

The study demonstrated a significant reduction in the number of resections over time, increased utilisation of a laparoscopic approach and a shift towards the care of IBD surgical patients being by a colorectal subspecialist. However, these changes do not correspond with improved surgical outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ghosh S, Mitchell R (2007) Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s and Colitis 1(1):10–20CrossRef Ghosh S, Mitchell R (2007) Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s and Colitis 1(1):10–20CrossRef
2.
Zurück zum Zitat Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S et al (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5(1):17–30CrossRef Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S et al (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5(1):17–30CrossRef
3.
Zurück zum Zitat Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778CrossRef Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778CrossRef
4.
Zurück zum Zitat Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018) ACG clinical guideline: management of Crohnʼs disease in adults. Am J Gastroenterol 113(4):481–517CrossRef Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018) ACG clinical guideline: management of Crohnʼs disease in adults. Am J Gastroenterol 113(4):481–517CrossRef
5.
Zurück zum Zitat Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK et al (2019) British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68(Suppl 3):s1-106CrossRef Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK et al (2019) British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68(Suppl 3):s1-106CrossRef
7.
Zurück zum Zitat Overview | Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy | Guidance | NICE [Internet]. NICE; [cited 2020 Jun 14]. Available from: https://www.nice.org.uk/guidance/ta329. Accessed from 14 Jun 2020 Overview | Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy | Guidance | NICE [Internet]. NICE; [cited 2020 Jun 14]. Available from: https://​www.​nice.​org.​uk/​guidance/​ta329. Accessed from 14 Jun 2020
9.
Zurück zum Zitat Frolkis AD, Dykeman J, Negrón ME, deBruyn J, Jette N, Fiest KM et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145(5):996–1006CrossRef Frolkis AD, Dykeman J, Negrón ME, deBruyn J, Jette N, Fiest KM et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145(5):996–1006CrossRef
10.
Zurück zum Zitat Ahmad A, Laverty AA, Alexakis C, Cowling T, Saxena S, Majeed A et al (2018) Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003–2013. BMJ Open Gastroenterology 5(1):e000191CrossRef Ahmad A, Laverty AA, Alexakis C, Cowling T, Saxena S, Majeed A et al (2018) Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003–2013. BMJ Open Gastroenterology 5(1):e000191CrossRef
11.
Zurück zum Zitat Goldstone RN, Steinhagen RM (2019) Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am 99(6):1141–1150CrossRef Goldstone RN, Steinhagen RM (2019) Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am 99(6):1141–1150CrossRef
13.
Zurück zum Zitat Baldock T, Brown L, McLean R (2019 Nov) Perforated diverticulitis in the North of England: trends in patient outcomes, management approach and the influence of subspecialisation. Annals 101(8):563–570CrossRef Baldock T, Brown L, McLean R (2019 Nov) Perforated diverticulitis in the North of England: trends in patient outcomes, management approach and the influence of subspecialisation. Annals 101(8):563–570CrossRef
14.
Zurück zum Zitat Brown LR, McLean RC, Perren D, O’Loughlin P, McCallum IJD (2019) Evaluating the effects of surgical subspecialisation on patient outcomes following emergency laparotomy: a retrospective cohort study. Int J Surg 62:67–73CrossRef Brown LR, McLean RC, Perren D, O’Loughlin P, McCallum IJD (2019) Evaluating the effects of surgical subspecialisation on patient outcomes following emergency laparotomy: a retrospective cohort study. Int J Surg 62:67–73CrossRef
15.
Zurück zum Zitat Boyd-Carson H, Doleman B, Herrod PJJ, Anderson ID, Williams JP, Lund JN et al (2019) Association between surgeon special interest and mortality after emergency laparotomy. Br J Surg 106(7):940–948CrossRef Boyd-Carson H, Doleman B, Herrod PJJ, Anderson ID, Williams JP, Lund JN et al (2019) Association between surgeon special interest and mortality after emergency laparotomy. Br J Surg 106(7):940–948CrossRef
16.
Zurück zum Zitat Health and Social Care Information Centre. Hospital Episode Statistics. 2015. Health and Social Care Information Centre. Hospital Episode Statistics. 2015.
17.
Zurück zum Zitat Aylin P, Bottle A, Jen MH, Middleton S (2009) HSMR mortality indicators. Imperial College, South Kensington Aylin P, Bottle A, Jen MH, Middleton S (2009) HSMR mortality indicators. Imperial College, South Kensington
18.
Zurück zum Zitat Education D of education and skills in your area: IDACI score and rank of IDACI. UK government. (2015) Education D of education and skills in your area: IDACI score and rank of IDACI. UK government. (2015)
19.
Zurück zum Zitat Clinical Indicators Team (2014) Analysis of the impact of deprivation on the Summary Hospital-level Mortality Indicator (SHMI). Health and Social Care Information Centre, London. p, p 6 Clinical Indicators Team (2014) Analysis of the impact of deprivation on the Summary Hospital-level Mortality Indicator (SHMI). Health and Social Care Information Centre, London. p, p 6
20.
Zurück zum Zitat Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251CrossRef Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251CrossRef
21.
Zurück zum Zitat Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef
22.
Zurück zum Zitat NELA Project Team. NELA Standalone RAG Table. 2018. NELA Project Team. NELA Standalone RAG Table. 2018.
26.
Zurück zum Zitat Freemantle N, Richardson M, Wood J, Ray D, Khosla S, Shahian D et al (2012) Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med 105(2):74–84CrossRef Freemantle N, Richardson M, Wood J, Ray D, Khosla S, Shahian D et al (2012) Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med 105(2):74–84CrossRef
27.
Zurück zum Zitat Freemantle N, Richardson M, Wood J, Ray D, Khosla S, Sun P et al (2013) Can we update the Summary Hospital Mortality Index (SHMI) to make a useful measure of the quality of hospital care? An observational study. BMJ Open 3(1):e002018CrossRef Freemantle N, Richardson M, Wood J, Ray D, Khosla S, Sun P et al (2013) Can we update the Summary Hospital Mortality Index (SHMI) to make a useful measure of the quality of hospital care? An observational study. BMJ Open 3(1):e002018CrossRef
28.
Zurück zum Zitat Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19(6):716–723CrossRef Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19(6):716–723CrossRef
29.
Zurück zum Zitat von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRef
30.
Zurück zum Zitat Abelson JS, Michelassi F, Mao J, Sedrakyan A, Yeo H (2018) Higher surgical morbidity for ulcerative colitis patients in the era of biologics. Ann Surg 268(2):311–317CrossRef Abelson JS, Michelassi F, Mao J, Sedrakyan A, Yeo H (2018) Higher surgical morbidity for ulcerative colitis patients in the era of biologics. Ann Surg 268(2):311–317CrossRef
31.
Zurück zum Zitat Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN (2017) Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 45(1):3–13CrossRef Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN (2017) Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 45(1):3–13CrossRef
32.
Zurück zum Zitat Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN et al (2017) Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol 112(12):1840–1848CrossRef Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN et al (2017) Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol 112(12):1840–1848CrossRef
33.
Zurück zum Zitat Singh S, Al-Darmaki A, Frolkis AD, Seow CH, Leung Y, Novak KL et al (2015) Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology 149(4):928–937CrossRef Singh S, Al-Darmaki A, Frolkis AD, Seow CH, Leung Y, Novak KL et al (2015) Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology 149(4):928–937CrossRef
34.
Zurück zum Zitat Kovacs C, Jarvis SW, Prytherch DR, Meredith P, Schmidt PE, Briggs JS et al (2016) Comparison of the national early warning score in non-elective medical and surgical patients: national early warning score in medical versus surgical patients. Br J Surg 103(10):1385–1393CrossRef Kovacs C, Jarvis SW, Prytherch DR, Meredith P, Schmidt PE, Briggs JS et al (2016) Comparison of the national early warning score in non-elective medical and surgical patients: national early warning score in medical versus surgical patients. Br J Surg 103(10):1385–1393CrossRef
35.
Zurück zum Zitat Burke J, Wood S, Hermon A, Szakmany T (2019) Improving outcome of sepsis on the ward: introducing the ‘Sepsis Six’ bundle: Sepsis Six to improve outcome. Nurs Crit Care 24(1):33–39CrossRef Burke J, Wood S, Hermon A, Szakmany T (2019) Improving outcome of sepsis on the ward: introducing the ‘Sepsis Six’ bundle: Sepsis Six to improve outcome. Nurs Crit Care 24(1):33–39CrossRef
36.
Zurück zum Zitat Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A et al (2018) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for Ileocolonic Crohn disease: results of a prospective nationwide cohort. Ann Surg 267(2):221–228CrossRef Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A et al (2018) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for Ileocolonic Crohn disease: results of a prospective nationwide cohort. Ann Surg 267(2):221–228CrossRef
37.
Zurück zum Zitat Lightner AL, McKenna NP, Alsughayer A, Harmsen WS, Taparra K, Parker ME et al (2019) Biologics and 30-day postoperative complications after abdominal operations for crohn’s disease: are there differences in the safety profiles? Dis Colon Rectum 62(11):1352–1362CrossRef Lightner AL, McKenna NP, Alsughayer A, Harmsen WS, Taparra K, Parker ME et al (2019) Biologics and 30-day postoperative complications after abdominal operations for crohn’s disease: are there differences in the safety profiles? Dis Colon Rectum 62(11):1352–1362CrossRef
38.
Zurück zum Zitat Biological therapy audit subgroup. National clinical audit of biological therapies UK inflammatory bowel disease (IBD) audit. Annual report September 2016. Royal college of physicians; Biological therapy audit subgroup. National clinical audit of biological therapies UK inflammatory bowel disease (IBD) audit. Annual report September 2016. Royal college of physicians;
39.
Zurück zum Zitat European Society of Coloproctology collaborating group (2018) Risk factors for unfavourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection An international audit by ESCP and S-ECCO. Colorectal Dis. 20(3):219–227CrossRef European Society of Coloproctology collaborating group (2018) Risk factors for unfavourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection An international audit by ESCP and S-ECCO. Colorectal Dis. 20(3):219–227CrossRef
40.
Zurück zum Zitat Cima RR (2005) Medical and surgical management of chronic ulcerative colitis. Arch Surg 140(3):300CrossRef Cima RR (2005) Medical and surgical management of chronic ulcerative colitis. Arch Surg 140(3):300CrossRef
42.
Zurück zum Zitat Sellers M, Sharoky CE, Keele LJ, Wirtalla C, Paulson EC, Karakousis GC et al (2017) Does specialization improve colorectal outcomes in emergency general surgery? J Am Coll Surg 225(4):e67CrossRef Sellers M, Sharoky CE, Keele LJ, Wirtalla C, Paulson EC, Karakousis GC et al (2017) Does specialization improve colorectal outcomes in emergency general surgery? J Am Coll Surg 225(4):e67CrossRef
43.
Zurück zum Zitat Martinez-Vinson C, Le S, Blachier A, Lipari M, Hugot J-P, Viala J (2020) Effects of introduction of an inflammatory bowel disease nurse position on healthcare use. BMJ Open 10(5):e036929CrossRef Martinez-Vinson C, Le S, Blachier A, Lipari M, Hugot J-P, Viala J (2020) Effects of introduction of an inflammatory bowel disease nurse position on healthcare use. BMJ Open 10(5):e036929CrossRef
Metadaten
Titel
Patient Outcomes Following Emergency Bowel Resection for Inflammatory Bowel Disease and the Impact of Surgical Subspecialisation in the North of England: A Retrospective Cohort Study
verfasst von
H. MacFarlane
T. E. Baldock
R. C. McLean
L. R. Brown
Publikationsdatum
27.01.2021
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 5/2021
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05947-8

Weitere Artikel der Ausgabe 5/2021

World Journal of Surgery 5/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.